Financial Consulting, with a Personal Touch
We can plan your brighter future!
We can plan your brighter future!
Saguaro Capital Partners ("Saguaro") is a specialized Financial Advisory firm providing a broad range of Investment Banking services to its clients, including equity financing, debt restructuring, merger & acquisition advisory and consulting expertise. Based in Scottsdale, Arizona, with offices in Denver, Colorado and Minneapolis, Minnesota, the firm advises clients throughout the western United States. With a focus on serving business owners and entrepreneurs, Saguaro offers its clients the expertise and capabilities of a large firm while preserving the energy, nimbleness and focus of a small boutique firm. The firm's founders have extensive experience in small market transactions (under $100M), as well as hands-on senior management experience in growing and running successful companies of varying sizes in many different industries.
I start by documenting your goals and then compare them to your current portfolio. I use proven investment strategies designed to meet your risk tolerance and stand up against market volatility. And you can count on unbiased recommendations and impartial guidance based directly on your needs and goals.
Saguaro's market focus is in two key areas: the life sciences (both medical device and pharmacology) and the internet-based application development industries. The firm's focus is on the private placements of growth equity and debt in amounts ranging between $5M to $50M. In certain circumstances, Saguaro also makes direct investments into privately held companies that fit the founder's investment criteria. I’m passionate about helping both companies and individuals with diversifying portfolios, managing assets, analyzing market trends, and reducing financial risk. My goal? To safeguard the dreams you strived to achieve and the assets you have worked so hard to accumulate. I use proven investment strategies designed to meet your risk tolerance and hedge against market volatility.
Access to equity capital in periods of high growth or distress is a critical component to the long-term success of a business. However, the process of raising equity capital is usually a full-time job in and of itself. Saguaro works with its clients to identify the appropriate source for equity capital (private or institutional) and to ensure that the amount of capital raised is sufficient to meet the needs of the business. Having a big sale, on-site celebrity, or other event? Be sure to announce it so everybody knows and gets excited about it.
In many cases, companies with strong growth prospects and a solid balance sheet can find it difficult to retain or attract fair priced long-term debt or operating credit facilities. The recession of 2008-2011 continues to have a profound impact on the availability of credit to small and medium-sized businesses, making the daily operations of many businesses very painful. Saguaro has extensive experience in assisting business owners to identify and secure the optimal debt instrument or operating credit facility that matches their business needs.
Acquiring or divesting a business can create significant value for business owners if the M&A process is properly managed and executed. Conversely, a poorly managed M&A process can result in significant lost value or a failed transaction. Saguaro has a lengthy record of successful transactions on both the buy side and the sell side of the table, and is strongly positioned to assist business owners when such an opportunity presents itself.
High growth or distressed companies can often lack leadership in key functional areas on their management team. The founders and associates of Saguaro are frequently asked to assume key management roles on a short-term or long-term basis in order for clients to operate their business. Some examples of positions that Saguaro has served for its clients in the past are CEO, CFO, Treasurer, Business Development and Operations Manager.
Ensuring that the intellectual property of a company is correctly filed and protected is a key component in driving both short-term and long-term value of each of our clients. Saguaro Capital Partners has a patent attorney on staff who reviews the intellectual property portfolio of each prospective client prior to entering into a formal engagement.
Todd S. Caven is an accomplished executive with 25 years of experience in corporate finance, taxation, mergers & acquisitions, corporate valuations and private financing of various types of transactions. In March of 2009, Mr. Caven co-founded Saguaro Capital Partners, an Arizona based firm that raises growth capital for medical device
Todd S. Caven is an accomplished executive with 25 years of experience in corporate finance, taxation, mergers & acquisitions, corporate valuations and private financing of various types of transactions. In March of 2009, Mr. Caven co-founded Saguaro Capital Partners, an Arizona based firm that raises growth capital for medical device and technology companies throughout the United States. Currently, Mr. Caven is a consultant of Regen BioPharma Inc, a San Diego, California based biotech research firm which has created an impressive volume of intellectual property in the fields of immune oncology and autoimmune disorders.
In 2003, Mr. Caven founded Rock Ridge Enterprises, a Minnesota-based boutique Private Equity firm that focuses on the acquisition of manufacturing, distribution, construction and business services firms in the upper Midwest. Prior to founding Rock Ridge Enterprises, he served as the CFO of Atterro Human Capital Group (formerly Pro Staff), a $500 million privately held firm in the Staffing and Recruiting industry. Prior to Atterro, Todd held senior-level finance and marketing positions at Nordic Track and the Carlson Companies in Minneapolis, Minnesota. He started his career in corporate finance at Amoco Corporation in Chicago, Illinois (now British Petroleum).
Todd earned a Bachelors degree in Accounting from the Tippie College of Business at the University of Iowa, and he received an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University.
Cris is an influential leader with a demonstrated ability to collaborate with executives and functional managers to shape long-term vision and execute strategic objectives. She possesses a well-rounded background in communications, marketing, design and product management. Cris is insightful and inquisitive, with a unique ability to i
Cris is an influential leader with a demonstrated ability to collaborate with executives and functional managers to shape long-term vision and execute strategic objectives. She possesses a well-rounded background in communications, marketing, design and product management. Cris is insightful and inquisitive, with a unique ability to identify trends and translate them into meaningful and realistic opportunities.
In her role, Cris oversees the overall day-to-day activities of the organization with a focus on the systems required to accomplish our clients mission and goals in the marketplace. She is responsible for creating the marketing strategy, managing the client experience and communicating the results of all client focused programs.
Cris attended the University of Minnesota and studied Marketing and Business Communication.
Regen BioPharma, Inc., a wholly-owned publicly traded subsidiary of Bio-Matrix Scientific Group, Inc., is a biotechnology company focused on identifying undervalued regenerative medicine applications in the stem cell space and rapidly advancing these technologies through preclinical and Phase I/II clinical trials. www.regenbiopharma.com
Biothera, founded in 1997, is a biotechnology company dedicated to improving immune health. The company has developed a natural gluco polysaccharide that engages and directs natural innate immune system responses. Currently, the company is commercializing this carbohydrate technology through two business groups: Pharmaceutical and Healthcare. www.biothera.com
Bio-Matrix Scientific Group, Inc., (OTCBB: BMSN) a development stage company, through its subsidiary, Regen BioPharma, Inc., intends to engage primarily in the development of regenerative medical applications. It develops HemaXellerate, a cellular drug to heal damaged bone marrow; and HemaXellerate I, which is a patient-specific composition of cells that have been demonstrated to repair damaged bone marrow and stimulate production of blood cells based on previous animal studies.
Send me a message, and tell me more about your financial goals and needs. I will get back to you soon to schedule a consultation.
821 Meander Court, Medina, MN 55340, USA
Monday - Friday: 9am - 5pm
Saturday: By appointment
Copyright © 2021 Saguaro Capital Partners - All Rights Reserved.